Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Proteostasis Therapeutics Inc (NASDAQ:PTI)

4.99
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
1.41
Today|||52-Week Range
16.67
-59.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.1M5.2M4.3M8.4M
 
 
 
 
 
Depreciation And Amortization608.0K427.0K272.0K306.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses16.1M20.4M28.6M45.5M
 
 
 
 
 
Research And Development13.0M16.7M22.5M34.0M
 
 
 
 
 
Total Operating Expenses16.7M20.8M28.8M45.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.6M-15.7M-24.5M-37.5M
 
 
 
 
 
Extraordinary Charge---76.0K-63.0K-7.0K
 
 
 
 
Interest Expense On Debt0.00199.0K599.0K0.00
 
 
 
Other Expenses-139.0K185.0K156.0K-16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.7M-15.8M-25.0M-37.2M
 
 
 
 
 
Preferred Dividend-6.9M-13.9M-1.7M-1.4M
 
 
 
 
 
Net Income-15.7M-15.8M-25.0M-37.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M24.9M24.9M18.8M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M24.9M24.9M18.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$1.19-$0.94-$2.06
 
 
 
 
 
EPS Diluted-$0.91-$1.19-$0.94-$2.06